Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.

<h4>Background</h4>The expression of BCL11B was reported in T-cells, neurons and keratinocytes. Aberrations of BCL11B locus leading to abnormal gene transcription were identified in human hematological disorders and corresponding animal models. Recently, the elevated levels of Bcl11b pro...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Piotr Grabarczyk, Viola Nähse, Martin Delin, Grzegorz Przybylski, Maren Depke, Petra Hildebrandt, Uwe Völker, Christian A Schmidt
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2010
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/c6bb91389b5b48bb9dad57bdc45f23a9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c6bb91389b5b48bb9dad57bdc45f23a9
record_format	dspace
spelling	oai:doaj.org-article:c6bb91389b5b48bb9dad57bdc45f23a92021-11-18T06:35:29ZIncreased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.1932-620310.1371/journal.pone.0012532https://doaj.org/article/c6bb91389b5b48bb9dad57bdc45f23a92010-09-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20824091/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The expression of BCL11B was reported in T-cells, neurons and keratinocytes. Aberrations of BCL11B locus leading to abnormal gene transcription were identified in human hematological disorders and corresponding animal models. Recently, the elevated levels of Bcl11b protein have been described in a subset of squameous cell carcinoma cases. Despite the rapidly accumulating knowledge concerning Bcl11b biology, the contribution of this protein to normal or transformed cell homeostasis remains open.<h4>Methodology/principal findings</h4>Here, by employing an overexpression strategy we revealed formerly unidentified features of Bcl11b. Two different T-cell lines were forced to express BCL11B at levels similar to those observed in primary T-cell leukemias. This resulted in markedly increased resistance to radiomimetic drugs while no influence on death-receptor apoptotic pathway was observed. Apoptosis resistance triggered by BCL11B overexpression was accompanied by a cell cycle delay caused by accumulation of cells at G1. This cell cycle restriction was associated with upregulation of CDKN1C (p57) and CDKN2C (p18) cyclin dependent kinase inhibitors. Moreover, p27 and p130 proteins accumulated and the SKP2 gene encoding a protein of the ubiquitin-binding complex responsible for their degradation was repressed. Furthermore, the expression of the MYCN oncogene was silenced which resulted in significant depletion of the protein in cells expressing high BCL11B levels. Both cell cycle restriction and resistance to DNA-damage-induced apoptosis coincided and required the histone deacetylase binding N-terminal domain of Bcl11b. The sensitivity to genotoxic stress could be restored by the histone deacetylase inhibitor trichostatine A.<h4>Conclusions</h4>The data presented here suggest a potential role of BCL11B in tumor survival and encourage developing Bcl11b-inhibitory approaches as a potential tool to specifically target chemoresistant tumor cells.Piotr GrabarczykViola NähseMartin DelinGrzegorz PrzybylskiMaren DepkePetra HildebrandtUwe VölkerChristian A SchmidtPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 9 (2010)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Piotr Grabarczyk Viola Nähse Martin Delin Grzegorz Przybylski Maren Depke Petra Hildebrandt Uwe Völker Christian A Schmidt Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.
description	<h4>Background</h4>The expression of BCL11B was reported in T-cells, neurons and keratinocytes. Aberrations of BCL11B locus leading to abnormal gene transcription were identified in human hematological disorders and corresponding animal models. Recently, the elevated levels of Bcl11b protein have been described in a subset of squameous cell carcinoma cases. Despite the rapidly accumulating knowledge concerning Bcl11b biology, the contribution of this protein to normal or transformed cell homeostasis remains open.<h4>Methodology/principal findings</h4>Here, by employing an overexpression strategy we revealed formerly unidentified features of Bcl11b. Two different T-cell lines were forced to express BCL11B at levels similar to those observed in primary T-cell leukemias. This resulted in markedly increased resistance to radiomimetic drugs while no influence on death-receptor apoptotic pathway was observed. Apoptosis resistance triggered by BCL11B overexpression was accompanied by a cell cycle delay caused by accumulation of cells at G1. This cell cycle restriction was associated with upregulation of CDKN1C (p57) and CDKN2C (p18) cyclin dependent kinase inhibitors. Moreover, p27 and p130 proteins accumulated and the SKP2 gene encoding a protein of the ubiquitin-binding complex responsible for their degradation was repressed. Furthermore, the expression of the MYCN oncogene was silenced which resulted in significant depletion of the protein in cells expressing high BCL11B levels. Both cell cycle restriction and resistance to DNA-damage-induced apoptosis coincided and required the histone deacetylase binding N-terminal domain of Bcl11b. The sensitivity to genotoxic stress could be restored by the histone deacetylase inhibitor trichostatine A.<h4>Conclusions</h4>The data presented here suggest a potential role of BCL11B in tumor survival and encourage developing Bcl11b-inhibitory approaches as a potential tool to specifically target chemoresistant tumor cells.
format	article
author	Piotr Grabarczyk Viola Nähse Martin Delin Grzegorz Przybylski Maren Depke Petra Hildebrandt Uwe Völker Christian A Schmidt
author_facet	Piotr Grabarczyk Viola Nähse Martin Delin Grzegorz Przybylski Maren Depke Petra Hildebrandt Uwe Völker Christian A Schmidt
author_sort	Piotr Grabarczyk
title	Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.
title_short	Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.
title_full	Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.
title_fullStr	Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.
title_full_unstemmed	Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.
title_sort	increased expression of bcl11b leads to chemoresistance accompanied by g1 accumulation.
publisher	Public Library of Science (PLoS)
publishDate	2010
url	https://doaj.org/article/c6bb91389b5b48bb9dad57bdc45f23a9
work_keys_str_mv	AT piotrgrabarczyk increasedexpressionofbcl11bleadstochemoresistanceaccompaniedbyg1accumulation AT violanahse increasedexpressionofbcl11bleadstochemoresistanceaccompaniedbyg1accumulation AT martindelin increasedexpressionofbcl11bleadstochemoresistanceaccompaniedbyg1accumulation AT grzegorzprzybylski increasedexpressionofbcl11bleadstochemoresistanceaccompaniedbyg1accumulation AT marendepke increasedexpressionofbcl11bleadstochemoresistanceaccompaniedbyg1accumulation AT petrahildebrandt increasedexpressionofbcl11bleadstochemoresistanceaccompaniedbyg1accumulation AT uwevolker increasedexpressionofbcl11bleadstochemoresistanceaccompaniedbyg1accumulation AT christianaschmidt increasedexpressionofbcl11bleadstochemoresistanceaccompaniedbyg1accumulation
_version_	1718424444452470784

Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.

Ejemplares similares